Cancer Treatment
Reports from the United States, Denmark and Canada describe recent advances in cancer treatment research
Published in Immunotherapy Weekly, August 23rd, 2006
Study 1: Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors.
According to a study from the United States, "A single intratumoral injection of IL-12 and GM-CSF-encapsulated microspheres induces the complete regression of advanced spontaneous tumors in her-2/neu transgenic mice. However, tumor regression in this model is transient and long-term cure is not achieved due to recurrence."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2006-08-23)
More Articles from Immunotherapy Weekly
- Allergy & Immunology
Researchers make progress in the battle against anaphylactic shock - Asthma
Montelukast improves pulmonary function measured by impulse oscillometry - HIV/AIDS Research
Viral Genetics' study of protein-based therapy for treating AIDS yields significant results - Immunotherapy
Immune responses specifically inhibited in vivo by c-MIR - Respiratory Medicine
Roflumilast shows promise for asthma and COPD treatment - Allergy & Immunology
Aspergillus-sensitized early airway response inhibited by a surfactant protein - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
